Causation Key For J&J In Philly Risperdal Fight
Bolstered by a March verdict clearing a Johnson & Johnson unit of liability despite a finding that its Risperdal warning labels were inadequate, the company is likely to keep the focus...To view the full article, register now.
Already a subscriber? Click here to view full article